(2R)-2-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]but-3-en-1-ol (34384-65-1)

Identification
Name:	(2R)-2-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]but-3-en-1-ol
Synonyms:	AC1L4AGQ;(2S)-2-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]but-3-en-1-ol;34384-65-1
CAS:	34384-65-1
Molecular Formula:	C₁₉H₂₄N₂O
Molecular Weight:	296.4067
InChI:	InChI=1/C19H24N2O/c1-2-13(12-22)14-7-9-21-10-8-16-15-5-3-4-6-17(15)20-19(16)18(21)11-14/h2-6,13-14,18,20,22H,1,7-12H2/t13-,14-,18+/m0/s1
Molecular Structure:
Properties
Flash Point:	249.1°C
Boiling Point:	488.2°C at 760 mmHg
Density:	1.2g/cm³
Refractive index:	1.652
Flash Point:	249.1°C
Safety Data

Other Product

2(5H)-Furanone,3-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-
methyl (2R)-2-[(2S,3R,12bS)-3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate sulfate (2:1) (salt) (non-preferred name)
methyl (2S)-2-[(2R,3Z,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate (non-preferred name)
methyl (2S)-2-[(2R,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate (non-preferred name)
3-(1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-1-yl)propan-1-ol
Strychnidine,10,11-didehydro-11-[(2S,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-(9CI)
Indolo[2,3-a]quinolizine-6-carboxylic acid,2-[(1Z)-2-carboxyethenyl]-1,2,3,4,6,7,12,- 12b-octahydro-3-(hydroxymethyl)-12-methyl- ,6-methyl ester,(2S,3S,6S,12bR)-
Pyrano[3,2-a]xanthene-8,11-dione,9-[(1S,2S,3E)-2-(acetyloxy)-1,3-dimethyl-3-pentenyl]-1,2,3,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-3-(1-hydroxy-1-methylethyl)-6a,12b-dimethyl-,(3R,4aR,6aR,12S,12aS,12bR)- (9CI)
Benz[a]anthracene-1,7,12(2H)-trione,4a-(a-D-glucopyranosyloxy)-3,4,4a,12b-tetrahydro-2,3,8-trihydroxy-3-methyl-12b-[[(2R,5R,6R)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-5-[(2-thio-a-D-glucopyranosyl)oxy]-,(2S,3R,4aS,12bR)-
Pyrano[3,2-a]xanthene-8,11-dione,9-[(1S,2R,3S)-2-(acetyloxy)-1,3-dimethylpentyl]-1,2,3,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-3-(1-hydroxy-1-methylethyl)-6a,12b-dimethyl-,(3R,4aR,6aS,12S,12aS,12bR)-
Pyrano[3,2-a]xanthene-8,11-dione,9-[(1S,2R,3S)-2-(acetyloxy)-1,3-dimethylpentyl]-1,2,3,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-3-(1-hydroxy-1-methylethyl)-6a,12b-dimethyl-,(3R,4aR,6aR,12S,12aS,12bR)-
Pyrano[3,2-a]xanthen-12(1H)-one,9-[(1S,2R,- 3S)-2-(acetyloxy)-1,3-dimethylpentyl]-2,3,4a,- 5,6,6a,12a,12b-octahydro-8,11-dihydroxy-3- (1-hydroxy-1-methylethyl)-6a,12b-dimethyl-,(3R,4aR,6aR,12aR,12bR)-
12H-1,12-Ethano-11H-pyrido[1,2,3-lm]pyrrolo- [2,3-d]carbazol-11-ol,10-[(2S,3E,12bS)-3- ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,- 3-a]quinolizin-2-yl]-2,3,11a,11b,13,13ahexahydro- 14-(2-hydroxyethylidene)-,(1S,- 3aR,11S,11aR,12R,13aS,14E)-
Benz[a]anthracene-1,7,12(2H)-trione,3,4,4a,12b-tetrahydro-2,3,4a,8-tetrahydroxy-3-methyl-5-(methylthio)-12b-[[(2R,5R,6R)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-,(2S,3R,4aR,12bR)- (9CI)
(3S,12bR)-3-[(2R)-1-methylpiperidin-2-yl]-1,3,4,12b-tetrahydropyrido[2,1-a][2]benzazepin-6(2H)-one
3H,7H-Furo[3,2-c:5,4-f']bis[1]benzopyran-10-ol,6b,12b-dihydro-3,3-dimethyl-11-(3-methyl-2-buten-1-yl)-, (6bR,12bR)-
(-)-2-(1α-Ethyl-1,2,3,4,6,7,12,12bα-octahydroindolo[2,3-a]quinolizin-1-yl)-2-oxoacetic acid
(7aS,12bR)-7a,12b-Dihydro-6,7a,10-trihydroxy-3,3-dimethyl-12b-(3-methyl-2-butenyl)-3H,7H-benzofuro[3,2-b]pyrano[2,3-h][1]benzopyran-7-one
Propanedioic acid,(1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-, dimethylester, cis-
3-ethenyl-9-methoxy-2-[(6-methoxy-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine